BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24523872.
- Also identified by DOI 10.1371/journal.pone.0087684 and PMC identifier 3921129.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosine kinase overexpressed in more that 60% of human breast carcinomas. The overexpression of BRK has been shown to sensitize mammary epithelial cells to mitogenic signaling and to promote cell proliferation and tumor formation. The molecular mechanisms of BRK have been unveiled by the identification and characterization of BRK target proteins. Downstream of tyrosine kinases 1 or Dok1 is a scaffolding protein and a substrate of several tyrosine kinases. Herein we show that BRK interacts with and phosphorylates Dok1 specifically on Y362. We demonstrate that this phosphorylation by BRK significantly downregulates Dok1 in a ubiquitin-proteasome-mediated mechanism. Together, these results suggest a novel mechanism of action of BRK in the promotion of tumor formation, which involves the targeting of tumor suppressor Dok1 for degradation through the ubiquitin proteasomal pathway.
Medical subject headings
- Breast Neoplasms
- DNA-Binding Proteins
- Gene Expression Regulation, Neoplastic
- Neoplasm Proteins
- Phosphoproteins
- Proteasome Endopeptidase Complex
- Protein-Tyrosine Kinases
- RNA-Binding Proteins